Lars Jessen

Lars Jessen

Partner
HamburgFrankfurt
About

Lars Jessen practices in the area of corporate law, with particular focus on private equity and M&A. He has in-depth experience advising investors and corporations on complex cross-border transactions, reorganizations, joint ventures, and management participation schemes.

Lars also advises opportunistic investors in distressed debt and restructurings on loan transactions as well as distressed M&A.

Areas of FocusLife SciencesTechnologyReal EstateCorporateMergers and AcquisitionsPrivate Equity
Professional QualificationsRechtsanwalt admitted with Rechtsanwaltskammer Frankfurt am Main

EXPERIENCE

  • Keensight Capital:
    • Advising on the acquisition of Centric Germany by portfolio company aconso AG.
    • Advising on the acquisition of a majority stake in the ACTICO Group.
    • Advising on the acquisition of a minority interest in Advancis Software & Services GmbH (Advancis).
    • Advising on an investment in the Swedish Bentley Endovascular Group AB, whose subsidiary Bentley InnoMed GmbH develops, manufactures and markets innovative products for the minimally invasive treatment of vascular afflictions.
    • Advising on an investment in aconso AG, an innovation leader in HR document management systems.
    • Advising on the acquisition of Quanos Solutions GmbH, a leading global provider of industrial aftersales and digital technical documentation software.
    • Advising on the acquisition of Onventis, a leading provider of cloud procurement solutions for SMEs in the DACH region, Benelux and Scandinavia.
  • Advising Synova Capital on the acquisition of Allgeier IT Services GmbH (now Avendis GmbH).
  • Advising Accel-KKR, as lead investor in a single-asset continuation fund managed by Maxburg, in relation to Securepoint GmbH.
  • Advising healthcare-focused European investment firm Mérieux Equity Partners on the acquisition of a majority stake in curea medical, a carve-out from McAirlaid’s.
  • Advising RQM+, a global leader in MedTech services, on the acquisition of CRO Dr. med. Kottmann GmbH & Co. KG, a contract research organization (CRO) based in Germany.
Languages
  • German
  • English

Awards

  • JUVE Ranking 2025/2026: Frequently recommended for private equity transactions and Venture Capital (2024/2025)
  • Legal 500 Germany 2025: Recommended for M&A: mid-sized deals (EUR100 - EUR500 million)
  • Handelsblatt in cooperation with Best Lawyers 2026/2027: Recommended for Corporate Law, M&A Law, Private Equity Law, and Real Estate Law
Education
  • Higher Regional Court Frankenthal, Second State Examination, 2002
  • University of Freiburg, First State Examination, 1999

Prior Experience

  • Partner at an international business law firm, 2021 – 2022
  • Partner at an international business law firm, 2016 – 2021
  • Partner at an international business law firm, 2011 – 2016
  • Partner at an international business law firm, 2009 – 2011
  • Associate at an international business law firm, 2002 – 2009

My latest insights

News
Abstract_Glass_Building_P_1065_PPT1910520

DLA Piper advises Keensight and aconso on the acquisition of AI-powered HR systems...

7 April 2026

News

DLA Piper advises on EUR340 million investment into innovation campus

27 January 2026

News

DLA Piper advises VDK Groep on acquisition of leading construction equipment provider...

1 December 2025

View All
CallvCardLinkedInPrint

Connect

Phone

+49 69 271 33 366
(Work, Frankfurt)
+49 162 10 61 026
(Work, Hamburg)